JENSCARE-B's Ken-Valve Transcatheter Aortic Valve System Receives Approval from Hong Kong Department of Health

Stock News

Jun 22

The company has announced that its transcatheter aortic valve system, Ken-Valve, has recently received approval from the Department of Health of the Hong Kong Special Administrative Region.

The firm is actively advancing the commercialization of this product within the Hong Kong market.

Owing to the product's distinct advantages, ongoing therapy promotion efforts, and extensive commercialization experience, Ken-Valve has already gained broad market recognition.

This latest approval from the Hong Kong Department of Health further validates the product's potential in treating aortic regurgitation, including cases with concurrent stenosis.

The company remains committed to fully accelerating the global commercialization process for Ken-Valve to further realize its long-term strategic objectives.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/1146719938"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1146719938\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1146719938?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-22 06:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1146719938","market":"nz","top_or_hot":-1,"title":"JENSCARE-B's Ken-Valve Transcatheter Aortic Valve System Receives Approval from Hong Kong Department of Health","media":"Stock News","content":"<p>The company has announced that its transcatheter aortic valve system, Ken-Valve, has recently received approval from the Department of Health of the Hong Kong Special Administrative Region.<br><br>The firm is actively advancing the commercialization of this product within the Hong Kong market.<br><br>Owing to the product's distinct advantages, ongoing therapy promotion efforts, and extensive commercialization experience, Ken-Valve has already gained broad market recognition.<br><br>This latest approval from the Hong Kong Department of Health further validates the product's potential in treating aortic regurgitation, including cases with concurrent stenosis.<br><br>The company remains committed to fully accelerating the global commercialization process for Ken-Valve to further realize its long-term strategic objectives.<br><br></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>JENSCARE-B's Ken-Valve Transcatheter Aortic Valve System Receives Approval from Hong Kong Department of Health</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJENSCARE-B's Ken-Valve Transcatheter Aortic Valve System Receives Approval from Hong Kong Department of Health\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-06-22 06:34</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>The company has announced that its transcatheter aortic valve system, Ken-Valve, has recently received approval from the Department of Health of the Hong Kong Special Administrative Region.<br><br>The firm is actively advancing the commercialization of this product within the Hong Kong market.<br><br>Owing to the product's distinct advantages, ongoing therapy promotion efforts, and extensive commercialization experience, Ken-Valve has already gained broad market recognition.<br><br>This latest approval from the Hong Kong Department of Health further validates the product's potential in treating aortic regurgitation, including cases with concurrent stenosis.<br><br>The company remains committed to fully accelerating the global commercialization process for Ken-Valve to further realize its long-term strategic objectives.<br><br></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09877","symbol_name":"健世科技-B","start_time":0,"source_url":"","article_id":"1146719938","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1146719938","pubTimestamp":1782081256,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"The company has announced that its transcatheter aortic valve system, Ken-Valve, has recently received approval from the Department of Health of the Hong Kong Special Administrative Region.The firm...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09877":"健世科技-B","BK1100":"医疗保健设备"},"translate_title":"JENSCARE-B的Ken-Valve经导管主动脉瓣系统获香港卫生署批准","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09877":1},"content_text":"The company has announced that its transcatheter aortic valve system, Ken-Valve, has recently received approval from the Department of Health of the Hong Kong Special Administrative Region.The firm is actively advancing the commercialization of this product within the Hong Kong market.Owing to the product's distinct advantages, ongoing therapy promotion efforts, and extensive commercialization experience, Ken-Valve has already gained broad market recognition.This latest approval from the Hong Kong Department of Health further validates the product's potential in treating aortic regurgitation, including cases with concurrent stenosis.The company remains committed to fully accelerating the global commercialization process for Ken-Valve to further realize its long-term strategic objectives.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}